Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FDG PET/CT”

471 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 471 results

Not applicableUnknownNCT01432002
What this trial is testing

FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast Cancer

Who this might be right for
Breast Neoplasm
University Hospital, Geneva 60
Not applicableUnknownNCT01089270
What this trial is testing

Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives

Who this might be right for
Parkinson Disease
Tel-Aviv Sourasky Medical Center 80
Not applicableWithdrawnNCT01789892
What this trial is testing

Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung Cancer

Who this might be right for
Lung Cancer
Ohio State University Comprehensive Cancer Center
Not applicableStudy completedNCT00867412
What this trial is testing

Randomized Study of Positron Emission Tomography - Computed Tomography (PET/CT) in Pre-Operative Staging of Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerThoracotomy
Rigshospitalet, Denmark 189
Not applicableUnknownNCT04996927
What this trial is testing

18F-FDG PET/CT to Evaluate pD-1 Monoclonal Antibody With First-line Chemotherapy in Advanced NSCLC

Who this might be right for
NSCLC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50
Testing effectiveness (Phase 2)Study completedNCT03416153
What this trial is testing

Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer

Who this might be right for
Oropharynx Cancer
University of Michigan Rogel Cancer Center 91
Not applicableUnknownNCT04826445
What this trial is testing

USE OF 18FDG PET-CT TO PREDICT THE RESPONSE OF MANDIBULAR OSTEORADIONECROSIS TO THE PENTOCLO PROTOCOL WITH DOCUMENTED ANTIBIOTHERAPY

Who this might be right for
Mandibular Osteoradionecrosis
Gustave Roussy, Cancer Campus, Grand Paris 75
Not applicableEnded earlyNCT04060745
What this trial is testing

Glucose Metabolism in Brown Adipose Tissue (BAT) in Young Healthy Men Evaluated by Deuterium Metabolic Imaging (DMI)

Who this might be right for
Type2 DiabetesObesityMetabolic Syndrome
University of Aarhus 10
Testing effectiveness (Phase 2)WithdrawnNCT01471418
What this trial is testing

The Use of PET/CT to Evaluate Synovitis in the Temporomandibular Joint (TMJ)

Who this might be right for
Temporomandibular JointConservative Treatment Therapy
University of Pennsylvania
Not applicableStudy completedNCT00450567
What this trial is testing

Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and Chemotherapy

Who this might be right for
Lung Cancer
Jonsson Comprehensive Cancer Center 36
Very early researchLooking for participantsNCT06914999
What this trial is testing

Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+13 more
Emory University
Not applicableEnded earlyNCT04685798
What this trial is testing

Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CT

Who this might be right for
Squamous Cell Carcinoma
Washington University School of Medicine 8
Not applicableUnknownNCT03572595
What this trial is testing

F-18 FDG- PETCT in Staging and Recurrent Colorectal Cancer

Who this might be right for
Colo-rectal CancerRecurrence
Assiut University 45
Not applicableStudy completedNCT01269970
What this trial is testing

Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy

Who this might be right for
Esophageal Carcinoma (Squamous Cell Carcinoma - Adenocarcinoma)
Universitaire Ziekenhuizen KU Leuven
Not applicableStudy completedNCT04851379
What this trial is testing

PLACE OF THE 18F-FDG-PET/CT IN THE DIAGNOSTIC WORKUP IN PATIENTS WITH CLASSICAL FEVER OF UNKNOWN ORIGIN (FUO)

Who this might be right for
Fever of Unknown Origin
University Hospital, Montpellier 44
Early research (Phase 1)Ended earlyNCT03029988
What this trial is testing

An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.

Who this might be right for
Liver MetastasesColorectal Carcinoma
Navidea Biopharmaceuticals 3
Not applicableNot Yet RecruitingNCT07127627
What this trial is testing

Characterization of Abdomino-pelvic Lesions by 18Fluorine- Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

Who this might be right for
Abdominal Sepsis
Assiut University 79
Not applicableStudy completedNCT03419221
What this trial is testing

Impact of 18 FDG PET/CT on the Management of Patients With Staphylococcus Aureus Bloodstream Infection

Who this might be right for
Staphylococcus Aureus
University Hospital, Montpellier 291
Testing effectiveness (Phase 2)Study completedNCT02888080
What this trial is testing

Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary Sarcoidosis

Who this might be right for
Pulmonary Sarcoidosis
Novartis Pharmaceuticals 40
Not applicableEnded earlyNCT00823810
What this trial is testing

Treatment Monitoring of Advanced Colorectal Cancer With 18F-FDG PET/CT

Who this might be right for
Colorectal Cancer
Turku University Hospital 20
Next Page
20